Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT.

Griffin SJ, Bethel MA, Holman RR, Khunti K, Wareham N, Brierley G, Davies M, Dymond A, Eichenberger R, Evans P, Gray A, Greaves C, Harrington K, Hitman G, Irving G, Lessels S, Millward A, Petrie JR, Rutter M, Sampson M, Sattar N, Sharp S.

Health Technol Assess. 2018 Apr;22(18):1-64. doi: 10.3310/hta22180.

2.

Anti-platelet therapy does not influence the outcome of patients undergoing hepatic resection for colorectal liver metastases, an observational study.

Boyd-Carson H, Irving G, Navarro AP, Cameron IC, Gomez DS; Nottingham HPB Surgery Group.

Int J Surg. 2018 May;53:59-64. doi: 10.1016/j.ijsu.2018.03.031. Epub 2018 Mar 16.

PMID:
29555531
3.

Patients' views on interactions with practitioners for type 2 diabetes: a longitudinal qualitative study in primary care over 10 years.

Dambha-Miller H, Silarova B, Irving G, Kinmonth AL, Griffin SJ.

Br J Gen Pract. 2018 Jan;68(666):e36-e43. doi: 10.3399/bjgp17X693917. Epub 2017 Dec 4.

4.

International variations in primary care physician consultation time: a systematic review of 67 countries.

Irving G, Neves AL, Dambha-Miller H, Oishi A, Tagashira H, Verho A, Holden J.

BMJ Open. 2017 Nov 8;7(10):e017902. doi: 10.1136/bmjopen-2017-017902. Review.

5.

Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes.

Griffin SJ, Leaver JK, Irving GJ.

Diabetologia. 2017 Sep;60(9):1620-1629. doi: 10.1007/s00125-017-4337-9. Epub 2017 Aug 2. Review.

6.

Should we screen for atrial fibrillation?

Lown M, Garrard J, Irving G, Edwards D, Hobbs FR, Mant J.

Br J Gen Pract. 2017 Jul;67(660):296-297. doi: 10.3399/bjgp17X691613. No abstract available.

7.

RETRACTION:  How blockchain-timestamped protocols could improve the trustworthiness of medical science.

Irving G, Holden J.

F1000Res. 2017 Jun 8;6:805. doi: 10.12688/f1000research.11888.1. eCollection 2017.

8.

Diallyl trisulfide attenuated n-hexane induced neurotoxicity in rats by modulating P450 enzymes.

Wang S, Li M, Wang X, Li X, Yin H, Jiang L, Han W, Irving G, Zeng T, Xie K.

Chem Biol Interact. 2017 Mar 1;265:1-7. doi: 10.1016/j.cbi.2017.01.013. Epub 2017 Jan 20.

PMID:
28115069
9.

The ecology of medical care on an isolated island in Okinawa, Japan: a retrospective open cohort study.

Kaneko M, Matsushima M, Irving G.

BMC Health Serv Res. 2017 Jan 14;17(1):37. doi: 10.1186/s12913-017-1979-8.

10.

Oxidative Stress Mediated Hippocampal Neuron Apoptosis Participated in Carbon Disulfide-Induced Rats Cognitive Dysfunction.

Wang S, Irving G, Jiang L, Wang H, Li M, Wang X, Han W, Xu Y, Yang Y, Zeng T, Song F, Zhao X, Xie K.

Neurochem Res. 2017 Feb;42(2):583-594. doi: 10.1007/s11064-016-2113-8. Epub 2016 Nov 29.

PMID:
27900598
11.

Which cuff should I use? Indirect blood pressure measurement for the diagnosis of hypertension in patients with obesity: a diagnostic accuracy review.

Irving G, Holden J, Stevens R, McManus RJ.

BMJ Open. 2016 Nov 3;6(11):e012429. doi: 10.1136/bmjopen-2016-012429. Review.

12.

Interventions to increase or decrease the length of primary care physicians' consultation.

Wilson AD, Childs S, Gonçalves-Bradley DC, Irving GJ.

Cochrane Database Syst Rev. 2016 Aug 25;(8):CD003540. doi: 10.1002/14651858.CD003540.pub3. Review.

PMID:
27560697
13.

After Achilles.

Irving G, Holden J.

Br J Gen Pract. 2016 May;66(646):238. doi: 10.3399/bjgp16X684913. No abstract available.

14.

The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials.

Hermanowicz N, Ellenbogen A, Irving G, Buchfuhrer M, Jaros MJ, Shang G, Kim R.

CNS Drugs. 2016 May;30(5):443-54. doi: 10.1007/s40263-016-0333-8.

PMID:
27095237
15.

The AGREE Reporting Checklist is useful for assessing the quality of clinical practice guideline development.

Irving G.

BMJ. 2016 Apr 12;353:i2027. doi: 10.1136/bmj.i2027. No abstract available.

PMID:
27071697
16.

How blockchain-timestamped protocols could improve the trustworthiness of medical science.

Irving G, Holden J.

Version 3. F1000Res. 2016 Feb 26 [revised 2017 Jan 1];5:222. doi: 10.12688/f1000research.8114.3. eCollection 2016. Retraction in: F1000Res. 2017 Jun 8;6:805.

17.

Pharmacological agents for the prevention of vestibular migraine.

Maldonado Fernández M, Birdi JS, Irving GJ, Murdin L, Kivekäs I, Strupp M.

Cochrane Database Syst Rev. 2015 Jun 21;(6):CD010600. doi: 10.1002/14651858.CD010600.pub2. Review.

PMID:
26093662
18.

Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy.

James MI, Iwuji C, Irving G, Karmokar A, Higgins JA, Griffin-Teal N, Thomas A, Greaves P, Cai H, Patel SR, Morgan B, Dennison A, Metcalfe M, Garcea G, Lloyd DM, Berry DP, Steward WP, Howells LM, Brown K.

Cancer Lett. 2015 Aug 10;364(2):135-41. doi: 10.1016/j.canlet.2015.05.005. Epub 2015 May 12.

19.

Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial.

Irving GR, Iwuji CO, Morgan B, Berry DP, Steward WP, Thomas A, Brown K, Howells LM.

Trials. 2015 Mar 24;16:110. doi: 10.1186/s13063-015-0641-1.

20.

The meaning of suffering in patients with advanced progressive cancer.

Ellis J, Cobb M, O'Connor T, Dunn L, Irving G, Lloyd-Williams M.

Chronic Illn. 2015 Sep;11(3):198-209. doi: 10.1177/1742395314565720. Epub 2015 Jan 30.

PMID:
25637944
21.

[SBU report "misses" persuasive evidence. Dietary supplements extends the life of malnourished elderly].

Cederholm T, Bosaeus I, Brummer R, Ellegård L, Irving GF, Larsson J, Thorell A, Rothenberg E.

Lakartidningen. 2014 Dec 16;111(51-52):2299-300. Swedish. No abstract available.

22.

Colchicine for pericarditis.

Alabed S, Cabello JB, Irving GJ, Qintar M, Burls A.

Cochrane Database Syst Rev. 2014 Aug 28;(8):CD010652. doi: 10.1002/14651858.CD010652.pub2. Review.

PMID:
25164988
23.

[Phosphate additives in food a potential public health risk. High phosphate levels can lead to cardiovascular disease].

Stenvinkel P, Irving GF, Wegener S, Eyre S, Rippe B, Segelmark M, Barany P, Samuelsson O.

Lakartidningen. 2014 Jul 2-15;111(27-28):1176-9. Review. Swedish. No abstract available.

24.

Cardiovascular disease and cancer compete for the outcome of death.

Irving G.

BMJ. 2014 Aug 19;349:g5227. doi: 10.1136/bmj.g5227. No abstract available.

PMID:
25138108
25.

Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.

Irving G, Tanenberg RJ, Raskin J, Risser RC, Malcolm S.

Int J Clin Pract. 2014 Sep;68(9):1130-40. doi: 10.1111/ijcp.12452. Epub 2014 May 18.

PMID:
24837444
26.

Examining the practice of generalist expertise: a qualitative study identifying constraints and solutions.

Reeve J, Dowrick CF, Freeman GK, Gunn J, Mair F, May C, Mercer S, Palmer V, Howe A, Irving G, Shiner A, Watson J.

JRSM Short Rep. 2013 Nov 21;4(12):2042533313510155. doi: 10.1177/2042533313510155. eCollection 2013 Dec.

27.

From patient uncertainty to WHO policy in two years: a GP's experience of preparing and maintaining a Cochrane review.

Irving G.

Eur J Gen Pract. 2014 Mar;20(1):74-7. doi: 10.3109/13814788.2013.828689. Epub 2013 Nov 6.

PMID:
24195593
28.

Global health: time for full integration into GP education.

Watson J, Shiner A, Pettigrew LM, Irving G.

Br J Gen Pract. 2013 May;63(610):271-2. doi: 10.3399/bjgp13X667358. No abstract available.

29.

Measures of promptness of cancer diagnosis in primary care.

Irving G, Holden J.

Br J Cancer. 2013 May 28;108(10):2186. doi: 10.1038/bjc.2013.193. Epub 2013 May 2. No abstract available.

30.

The John Henry effect.

Irving G, Holden J.

BMJ. 2013 Apr 2;346:f1804. doi: 10.1136/bmj.f1804. No abstract available.

PMID:
23550069
31.

The time-efficiency principle: time as the key diagnostic strategy in primary care.

Irving G, Holden J.

Fam Pract. 2013 Aug;30(4):386-9. doi: 10.1093/fampra/cmt007. Epub 2013 Mar 27.

32.

Chronic heart failure guidelines: do they adequately address patient need at the end-of-life?

Irving G, Holden J, Edwards J, Reeve J, Dowrick C, Lloyd-Williams M.

Int J Cardiol. 2013 Oct 3;168(3):2304-9. doi: 10.1016/j.ijcard.2013.01.189. Epub 2013 Mar 7. Review.

33.

Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patients.

Jensen MP, Irving G, Rauck R, Wallace M, Sweeney M, Vanhove GF.

Clin J Pain. 2013 Sep;29(9):770-4. doi: 10.1097/AJP.0b013e31827b32ab.

PMID:
23370075
34.

Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians.

Irving G.

Ther Adv Chronic Dis. 2012 Sep;3(5):211-8. doi: 10.1177/2040622312452905.

35.

Dismantling Lord Moran's ladder: the primary care expert generalist.

Reeve J, Irving G, Freeman G.

Br J Gen Pract. 2013 Jan;63(606):34-5. doi: 10.3399/bjgp13X660823. No abstract available.

36.

Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration--a clinical pilot study including assessment of patient acceptability.

Irving GR, Howells LM, Sale S, Kralj-Hans I, Atkin WS, Clark SK, Britton RG, Jones DJ, Scott EN, Berry DP, Hemingway D, Miller AS, Brown K, Gescher AJ, Steward WP.

Cancer Prev Res (Phila). 2013 Feb;6(2):119-28. doi: 10.1158/1940-6207.CAPR-12-0281. Epub 2012 Dec 11.

37.

Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.

Rauck RL, Irving GA, Wallace MS, Vanhove GF, Sweeney M.

J Pain Symptom Manage. 2013 Aug;46(2):219-28. doi: 10.1016/j.jpainsymman.2012.07.011. Epub 2012 Nov 11.

PMID:
23149085
38.

Global health in the UK's GP postgraduate curriculum.

Irving G, Riley B, Rughani A, Pettigrew L, Watson J, Shiner A, Hibble A, Allen J; Royal College of General Practitioners Curriculum Development Committee.

Lancet. 2012 Nov 10;380(9854):1646-7. doi: 10.1016/S0140-6736(12)61947-3. No abstract available.

PMID:
23141613
39.

Do GPs really provide 47 minutes a year for the patient?

Irving G, Reeve J.

Br J Gen Pract. 2012 Aug;62(601):404-5. doi: 10.3399/bjgp12X653499. No abstract available.

40.

Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia.

Irving GA, Sweeney M.

J Pain Res. 2012;5:203-8. doi: 10.2147/JPR.S32562. Epub 2012 Jun 25.

41.

Hepatitis A immunisation in persons not previously exposed to hepatitis A.

Irving GJ, Holden J, Yang R, Pope D.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD009051. doi: 10.1002/14651858.CD009051.pub2. Review.

PMID:
22786522
42.

15 Minute consultations as standard benefit patients and GPs.

Irving GJ, Holden J.

BMJ. 2012 Jun 1;344:e3704. doi: 10.1136/bmj.e3704. No abstract available.

PMID:
22661722
43.

Long-term protective effects of hepatitis A vaccines. A systematic review.

Ott JJ, Irving G, Wiersma ST.

Vaccine. 2012 Dec 17;31(1):3-11. doi: 10.1016/j.vaccine.2012.04.104. Epub 2012 May 17. Review.

44.

Calling time on the 10-minute consultation.

Irving G, Holden J.

Br J Gen Pract. 2012 May;62(598):238-9. doi: 10.3399/bjgp12X641375. No abstract available.

45.

Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study.

Vedin I, Cederholm T, Freund-Levi Y, Basun H, Garlind A, Irving GF, Eriksdotter-Jönhagen M, Wahlund LO, Dahlman I, Palmblad J.

PLoS One. 2012;7(4):e35425. doi: 10.1371/journal.pone.0035425. Epub 2012 Apr 24.

46.

Once-daily gastroretentive gabapentin for treatment of postherpetic neuralgia.

Irving G.

Pain Manag. 2012 May;2(3):259-65. doi: 10.2217/pmt.12.20.

PMID:
24654668
47.

A pause for thought: reflections on the 2011 SAPC Annual Conference.

Reeve J, Abholz H, Bailey T, Bates E, Bond C, Chauhan U, Eldridge S, Irving G, Keong D, Mughal F, Nicum S, Singh S, Taylor C, Younie L; Society for Academic Primary Care.

Prim Health Care Res Dev. 2011 Oct;12(4):393-4. doi: 10.1017/S1463423611000430. No abstract available.

PMID:
22284950
48.

Curcumin: the potential for efficacy in gastrointestinal diseases.

Irving GR, Karmokar A, Berry DP, Brown K, Steward WP.

Best Pract Res Clin Gastroenterol. 2011 Aug;25(4-5):519-34. doi: 10.1016/j.bpg.2011.09.005. Review.

PMID:
22122768
49.

Can generalism help revive the primary healthcare vision?

Reeve J, Irving G, Dowrick CF.

J R Soc Med. 2011 Oct;104(10):395-400. doi: 10.1258/jrsm.2011.110097. No abstract available.

50.

Management of chronic noncancer pain in depressed patients.

Barkin RL, Barkin SJ, Irving GA, Gordon A.

Postgrad Med. 2011 Sep;123(5):143-54. doi: 10.3810/pgm.2011.09.2470. Review.

PMID:
21904097

Supplemental Content

Loading ...
Support Center